Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.92 -0.16 (-2.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phathom Pharmaceuticals (PHAT) Interest & Investment Income (2019 - 2026)

Updated

Phathom Pharmaceuticals (PHAT) posted Interest & Investment Income of $1.51 million for Q2 2026, down 15.5% from $1.79 million a year earlier and down 13.0% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Interest & Investment Income (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Phathom Pharmaceuticals was $5.86 million, down 49.7% year-over-year; for FY2025, it came in at $7.04 million, down 53.5% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 45.2% (FY2020 to FY2025).
  • In prior years, Phathom Pharmaceuticals' Interest & Investment Income was $15.16 million in FY2024 (+92.5%), $7.88 million in FY2023 (+269.4%), $2.13 million in FY2022 and $41,000 in FY2021 (-96.2%).
  • Quarterly Interest & Investment Income has run from a low of $6,000 in Q4 2021 to a high of $4.31 million in Q1 2024 over five years.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last six quarters, with an average decline of 28.2% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2024, with growth of 941.4%; the weakest was Q4 2025, with a decline of 65.7%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $1.74 million (Q1 2026), $1.2 million (Q4 2025) and $1.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Phathom Pharmaceuticals 554.08 Mn -85.87 Mn 59.18 Mn 1.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.51 Mn
Mar 31, 2026 1.74 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.41 Mn
Jun 30, 2025 1.79 Mn
Mar 31, 2025 2.64 Mn
Dec 31, 2024 3.51 Mn
Sep 30, 2024 3.71 Mn
Jun 30, 2024 3.62 Mn
Mar 31, 2024 4.31 Mn
Dec 31, 2023 3.35 Mn
Sep 30, 2023 2.72 Mn
Jun 30, 2023 348,000.00
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 726,000.00
Jun 30, 2022 112,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 8,000.00
API Access

Phathom Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PHAT&period=max&api_key=YOUR_API_KEY